Small molecule-mediated upregulation of CCR7 ameliorates murine experimental autoimmune encephalomyelitis by accelerating T-cell homing
Small molecule-mediated upregulation of CCR7 ameliorates murine experimental autoimmune encephalomyelitis by accelerating T-cell homing
复制标题
小分子介导的 CCR7 上调通过加速 T 细胞归巢来改善小鼠实验性自身免疫性脑脊髓炎
DOI:
10.1016/j.intimp.2017.10.004
复制
发表时间:
2017
影响因子:
5.6
通讯作者:
Xu Qiang
中科院分区:
文献类型:
--
作者:
Li Xin;Lu Tingting;Xue Wenwen;Wang Yixuan;Luo Qiong;Ge Huiming;Tan Renxiang;Shen Yan;Xu Qiang
Impairing the infiltration of immune cells into the CNS is a promising target for suppressing the development of multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Here, we found that oral administration of a synthetic small molecular compound Fc24 showed potential preventive effects on the development of EAE, including the reduction in EAE severity and a delay in the onset of the disease. Fc24 facilitated the accumulation of both CD4+and CD8+T cells within spleen and lymph nodes, while having no effect on MOG-specific T cell responses. Furthermore, CCR7 expression was upregulated by Fc24 on activated T cellsin vivoandin vitro, accompanied by ERK activation in the treated T cells in response to CCL19. These findings demonstrate that small molecule-mediated CCR7 upregulation might ameliorate EAE by facilitating T cell homing into and within lymphoid organs, and that Fc24 may be a potential candidate for modifying the development of EAE.